News
FYR Diagnostics, Texas A&M University, and University of New Mexico awarded NIH grant for early detection of Neonatal Opioid Withdrawal Syndrome (NOWS)
September 4, 2022 /
Newborns develop Neonatal Opioid Withdrawal Syndrome (NOWS) when the mother is exposed to opioids and passes exposure to their unborn child. NOWS cases surged from 1.5 per 1,000 hospital births in 2004 to 8 per 1,000 in 2014. Symptoms of NOWS in newborns range from mild and temporary to prolonged hospitalization with complications. Variability in the presentation of signs has led to delayed treatment decisions until the onset of withdrawal symptoms. Yet, delays in pharmacologic interventions lead to the risk of increased infant morbidity.
MATR Supporters (view all)
Posted in: Biotech, Regional Business News
Sorry, we couldn't find any posts. Please try a different search.